Alpha-fetoprotein-producing Gastric Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-12-17
Clinical Trial Update: Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC) [Phase 2]
Phase 2 trial investigating a quadruple combination of Iparomlimab, Tuvonralimab, Apatinib, and Irinotecan hydrochloride for advanced Alpha-…